Medlab Ascending Channel(ASX:MDC) Medlab Clinical Ltd is an Australian, publicly listed biotechnology company that is finding new ways to address the biggest challenges of our time including the growing burden of cancer, suboptimal pain management as well as enhancing drug delivery with nanotechnology.
Bullish Outlook:
-
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.93 AUD
−2.13 M AUD
11.89 K AUD
1.68 M
About MEDLAB CLINICAL LIMITED
Medlab Clinical Ltd. is a biotechnology company, which engages in the development of nutraceutical products for chronic diseases and mental health conditions. It operates through the Nutraceutical and Pharmaceutical Research segments. The Pharmaceutical Research segment focuses on depression and oncology, and the supply of cannabis-based medicines. The company was founded by Sean Hall on June, 2012 and is headquartered in Perth, Australia.
Flag attack?There is a nice bullish flag!
Last week we dipped down to the flag body`s bottom edge and kissed the EMA 200 there. Buyers came into the market here!
There are clear tradingmarks now:
1. Anticyclical Counter trade: Entry now, sl ~ 0,65 (near below the last low=flag Bodys bottom edge) and TP 0,9 =
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MDC is 6.60 AUD — it has decreased by −4.21% in the past 24 hours. Watch MEDLAB CLINICAL LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MEDLAB CLINICAL LIMITED stocks are traded under the ticker MDC.
MDC stock is 4.39% volatile and has beta coefficient of −11.40. Track MEDLAB CLINICAL LIMITED stock price on the chart and check out the list of the most volatile stocks — is MEDLAB CLINICAL LIMITED there?
Today MEDLAB CLINICAL LIMITED has the market capitalization of 15.07 M, it has decreased by −0.86% over the last week.
Yes, you can track MEDLAB CLINICAL LIMITED financials in yearly and quarterly reports right on TradingView.
MEDLAB CLINICAL LIMITED is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
MDC net income for the last half-year is −150.37 K AUD, while the previous report showed −1.98 M AUD of net income which accounts for 92.41% change. Track more MEDLAB CLINICAL LIMITED financial stats to get the full picture.
No, MDC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDLAB CLINICAL LIMITED EBITDA is −2.26 M AUD, and current EBITDA margin is −18.99 K%. See more stats in MEDLAB CLINICAL LIMITED financial statements.
Like other stocks, MDC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDLAB CLINICAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDLAB CLINICAL LIMITED technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDLAB CLINICAL LIMITED stock shows the sell signal. See more of MEDLAB CLINICAL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.